Altshuler Shaham Ltd Sells 289,995 Shares of Nutrien Ltd. $NTR
by Amy Steele · The Cerbat GemAltshuler Shaham Ltd decreased its position in shares of Nutrien Ltd. (NYSE:NTR – Free Report) by 13.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,853,201 shares of the company’s stock after selling 289,995 shares during the quarter. Nutrien accounts for 1.7% of Altshuler Shaham Ltd’s investment portfolio, making the stock its 21st largest holding. Altshuler Shaham Ltd’s holdings in Nutrien were worth $114,380,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Swiss Life Asset Management Ltd raised its stake in Nutrien by 23.6% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 79,770 shares of the company’s stock worth $4,691,000 after acquiring an additional 15,230 shares during the period. Van ECK Associates Corp raised its position in shares of Nutrien by 1.4% during the third quarter. Van ECK Associates Corp now owns 1,854,650 shares of the company’s stock valued at $108,901,000 after buying an additional 25,588 shares during the last quarter. MH & Associates Securities Management Corp ADV bought a new stake in shares of Nutrien during the fourth quarter valued at approximately $1,967,000. Hudson Bay Capital Management LP raised its position in shares of Nutrien by 190.3% during the third quarter. Hudson Bay Capital Management LP now owns 116,312 shares of the company’s stock valued at $6,829,000 after buying an additional 76,244 shares during the last quarter. Finally, Black Creek Investment Management Inc. raised its position in shares of Nutrien by 57.3% during the third quarter. Black Creek Investment Management Inc. now owns 2,367,244 shares of the company’s stock valued at $139,050,000 after buying an additional 862,487 shares during the last quarter. Institutional investors own 63.10% of the company’s stock.
Nutrien Stock Down 1.7%
NYSE:NTR opened at $64.39 on Thursday. Nutrien Ltd. has a twelve month low of $53.03 and a twelve month high of $85.36. The company has a market cap of $30.86 billion, a price-to-earnings ratio of 13.11, a price-to-earnings-growth ratio of 0.60 and a beta of 0.60. The stock has a fifty day simple moving average of $70.73 and a 200-day simple moving average of $69.43. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35.
Nutrien (NYSE:NTR – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. During the same period last year, the company earned $0.11 earnings per share. The business’s revenue for the quarter was up 18.5% compared to the same quarter last year. Analysts anticipate that Nutrien Ltd. will post 5.45 EPS for the current year.
Nutrien Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be given a $0.55 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.4%. Nutrien’s payout ratio is presently 44.81%.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on NTR. Royal Bank Of Canada lifted their price objective on shares of Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Tuesday, April 7th. Raymond James Financial upgraded shares of Nutrien from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $74.00 to $90.00 in a research report on Tuesday, May 5th. Wall Street Zen cut shares of Nutrien from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Morgan Stanley lifted their price objective on shares of Nutrien from $77.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, April 8th. Finally, Bank of America upgraded shares of Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective on the stock in a research report on Thursday, April 30th. Eleven analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $81.71.
Nutrien Company Profile
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Featured Articles
- Five stocks we like better than Nutrien
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR – Free Report).